Literature DB >> 21926526

The process of managing medications in patients with borderline personality disorder.

Kenneth R Silk1.   

Abstract

Patients with borderline personality disorder (BPD) are a challenge to treat both psychotherapeutically and psychopharmacologically. While a set of effective psychotherapeutic interventions for BPD has now emerged, no hard evidence exists concerning the effectiveness of any psychopharmacologic agent for the core symptoms of BPD. Nonetheless, more than 75% of patients with BPD regularly take psychotropic medications. Given the complex interpersonal interactions of these patients as well as their obvious psychological pain, it would be helpful if we could begin to discuss the nuts and bolts of prescribing psychotropic medications for patients with BPD with the goal of assisting the psychopharmacologist in this process of prescribing. This paper is an attempt to begin such a discussion of the process of prescribing medications to patients with BPD. The suggestions presented in this article should be considered only the beginning of a dialogue that will surely become more complex and demand increased clinical acumen and more rigorous scientific study as we continue to learn more about these complicated and multi-faceted patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926526     DOI: 10.1097/01.pra.0000405361.88257.4a

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  2 in total

1.  Effectiveness and tolerability of long-acting intramuscular risperidone as adjuvant treatment in refractory borderline personality disorder.

Authors:  J L Carrasco; N Palomares; M Díaz Marsá
Journal:  Psychopharmacology (Berl)       Date:  2012-10-11       Impact factor: 4.530

2.  Prescribing for personality disorder: qualitative study of interviews with general and forensic consultant psychiatrists.

Authors:  Lawrence Martean; Chris Evans
Journal:  Psychiatr Bull (2014)       Date:  2014-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.